RK-251 was announced by Indian researchers as a smart cancer drug designed to remain inactive in healthy tissues and activate inside tumour cells

RK-251 was announced by Indian researchers as a smart cancer drug designed to remain inactive in healthy tissues and activate inside tumour cells

¨     RK-251 was announced by Indian researchers on 19 August 2026 as a smart cancer drug designed to remain inactive in healthy tissues and activate inside tumour cells.

¨     The drug was developed through a collaboration led by Dr Asis Bala of the Institute of Advanced Study in Science and Technology (IASST) and Dr K.P. Bhabak of IIT Guwahati.

¨     RK-251 has been designed as a prodrug.

¨     A prodrug is a compound that becomes active only after a specific chemical trigger.

¨     In RK-251, the trigger is Reactive Oxygen Species (ROS).

¨     Many cancer cells contain higher levels of ROS than normal cells.

¨     ROS activates RK-251 within the tumour microenvironment.

¨     Once activated, RK-251 releases NBDHEX, an anticancer compound.

¨     NBDHEX blocks proteins that cancer cells use for survival.

¨     The design aims to target cancer cells more selectively and reduce exposure of healthy cells to the active drug.

¨     Preclinical laboratory studies tested RK-251 against aggressive triple-negative breast cancer (TNBC) cells.

¨     TNBC is a subtype of breast cancer that lacks oestrogen receptor, progesterone receptor, and HER2 expression.

¨     In laboratory conditions, RK-251 showed targeted activity against TNBC cells while sparing healthy cells.

¨     Toxicity and behavioural studies were conducted using zebrafish embryos, scientifically known as Danio rerio.

¨     The studies found no obvious signs of toxicity in the tested conditions.

¨     Fluorescence-based tests confirmed activation of RK-251 in high-ROS environments.

¨     The Institute of Advanced Study in Science and Technology (IASST) is a research institution located in Assam.

¨     IIT Guwahati is an Institute of National Importance under the Ministry of Education.

¨     The Department of Science and Technology (DST) is the central government department that supports scientific research and technology development in India.

¨     The key feature of RK-251 is its ROS-activated prodrug mechanism, designed to activate the anticancer compound primarily within cancer cells.